NASDAQ: ANIXAnixa Biosciences Inc Stock Ownership - Who owns Anixa Biosciences?
Insider buying vs selling
Have Anixa Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Catelani | President COO CFO | 2023-04-28 | 865 | $3.47 | $3.00kBuy |
| Michael Catelani | President COO CFO | 2022-10-31 | 1,069 | $2.81 | $3.00kBuy |
| Lewis H. Titterton Jr. | Director | 2022-09-29 | 40,000 | $2.58 | $103.00kBuy |
| Amit Kumar | Chief Executive Officer | 2022-09-15 | 491,900 | $4.48 | $2.20MSell |
| Amit Kumar | Chief Executive Officer | 2022-09-15 | 640,000 | $2.58 | $1.65MBuy |
| Lewis H. Titterton Jr. | Director | 2022-06-24 | 16,000 | $2.58 | $41.20kBuy |
| Lewis H. Titterton Jr. | Director | 2022-06-24 | 30,000 | $2.58 | $77.25kBuy |
ANIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ANIX insiders and whales buy or sell their stock.
ANIX Shareholders
What type of owners hold Anixa Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Mars Overseas Ltd | 64.67% | 20,000,000 | $69.60M | Insider |
| Frank J. Disanto | 5.77% | 1,785,905 | $6.21M | Insider |
| Vanguard Group Inc | 4.33% | 1,338,177 | $4.66M | Institution |
| Denis A. Krusos | 3.78% | 1,169,880 | $4.07M | Insider |
| Tisha Stender | 2.59% | 800,000 | $2.78M | Insider |
| Lewis H. Titterton Jr. | 2.50% | 774,070 | $2.69M | Insider |
| Ubs Group Ag | 2.07% | 638,996 | $2.22M | Institution |
| Bruce F. Johnson | 1.79% | 554,817 | $1.93M | Insider |
| Kent B. Williams | 1.53% | 473,910 | $1.65M | Insider |
| Amit Kumar | 1.49% | 462,100 | $1.61M | Insider |
ANIX vs Diagnostic & Research Stocks
Anixa Biosciences Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.